28 results on '"Goussot, Vincent"'
Search Results
2. Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?
3. Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach
4. Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study
5. Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC.
6. Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients
7. ACE et diagnostic précoce de récidive dans les différents sous-types moléculaires de cancer du sein : comparaison au CA 15-3
8. Intérêt clinique du CA 15-3 dans la détection précoce des récidives de cancer du sein localement avancé
9. Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
10. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study
11. Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use
12. A novel POLD1 pathogenic variant identified in two families with a cancer spectrum mimicking lynch syndrome
13. A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers
14. TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
15. TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing
16. Further delineation of theNTHL1associated syndrome: A report from the French Oncogenetic Consortium
17. Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.
18. Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer
19. Clinical value of CEA for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3
20. Identification and validation of a factor of commutability between platelet counts performed on EDTA and citrate
21. Validation steps for the detection of L858R mutation in EGFR gene by real time quantitative PCR
22. Le CA 125 dans le bilan d'extension des cancers du sein nouvellement diagnostiqués : pourquoi et comment ?.
23. Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
24. Intérêt clinique du CA 15-3 pour la détection des métastases des cancers du sein nouvellement diagnostiqués.
25. Intérêt clinique de l'ACE pour la détection des métastases des cancers du sein nouvellement diagnostiqués : comparaison au CA 15-3.
26. Détermination et validation d'un facteur de commutabilité entre les numérations plaquettaires réalisées sur EDTA et sur citrate de sodium.
27. Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management.
28. [CA 125 assay in the extension assessment of newly diagnosed breast cancers: why and how?]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.